artoo
artoo makes any-to-any clinical dataset conversion lossless by construction.
A side-by-side editorial comparison of inlabru and PowerTOST — release velocity, themes, recent moves, and the top alternatives to consider.
A Bayesian spatial modelling package rebuilding its foundations one breaking release at a time
inlabru wraps INLA for spatial, point-process and latent-Gaussian models in R. It is mid-modernisation: since 2.12.0 cut the sp stack, each release has renamed part of the public surface, standardised how external packages attach custom mappers, or replaced internal machinery. 2.15.0 is the latest step, pairing a new predictor evaluation and linearisation implementation with broom's tidy(), glance() and augment() methods and four non-zero-truncated observation families.
A bioequivalence sample-size workhorse whose news is which regulator it now covers
PowerTOST computes power and sample size for bioequivalence and its changelog reads as a record of regulatory divergence more than statistical development. Version 1.5-3 added the Gulf Co-operation Council as a regulator setting; 1.5-4 and 1.5-6 stripped 'FDA' out of the narrow-therapeutic-index function names once China's CDE began requiring the same evaluation. The most recent release, 1.5-7, is a single fix to how nvec() splits a total sample size across sequences.
inlabru wraps INLA for spatial, point-process and latent-Gaussian models in R. It is mid-modernisation: since 2.12.0 cut the sp stack, each release has renamed part of the public surface, standardised how external packages attach custom mappers, or replaced internal machinery. 2.15.0 is the latest step, pairing a new predictor evaluation and linearisation implementation with broom's tidy(), glance() and augment() methods and four non-zero-truncated observation families.
The arc is consolidation of the extension surface rather than expansion of the model catalogue. Every release adds mappers or families with one hand and removes a dependency, a re-export or a deprecated path with the other — plyr in 2.15.0, fmesher's Depends entry in 2.14.1, sp and ggmap in 2.12.0. The compatibility flag bru_compat_pre_2_14_enable and the temporary fm_int/fm_pixels re-exports show a maintainer sequencing breaks across releases instead of landing them together.
The 2.14 compatibility flag is still defaulting to TRUE and the fmesher re-exports are described in the entries as temporary, so the next obvious move is a release that flips bru_compat_pre_2_14_enable off and drops those re-exports.
PowerTOST computes power and sample size for bioequivalence and its changelog reads as a record of regulatory divergence more than statistical development. Version 1.5-3 added the Gulf Co-operation Council as a regulator setting; 1.5-4 and 1.5-6 stripped 'FDA' out of the narrow-therapeutic-index function names once China's CDE began requiring the same evaluation. The most recent release, 1.5-7, is a single fix to how nvec() splits a total sample size across sequences.
The package is in long maintenance with a widening regulatory surface: the statistical methods are settled, and releases arrive when an agency publishes a framework that can be expressed as a settings variant of an existing method. Function naming has been deliberately decoupled from any single agency, with the deprecated FDA-suffixed aliases carried for years before removal. Cadence has slowed to roughly one release every eighteen months.
The next release is most likely another regulator setting or a small fix; on the deprecation notice already given, the power.NTIDFDA()-style aliases are the obvious removal candidate.
Other Infra & APIs products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either inlabru or PowerTOST.
artoo makes any-to-any clinical dataset conversion lossless by construction.
tabular went from clinical tables to complete TFL output in under two months.
usmapdata ships its 2025 shapefiles on the year-indexed model it adopted in 0.4.0.
glcdp reaches 1.0.0 with a stable schema contract behind its data explorer.
prova adds expected-utility calculation on top of its Bayesian inference core.
checkhelper grew from a check wrapper into a CRAN pre-submission auditor.
See all inlabru alternatives → · See all PowerTOST alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
They serve adjacent needs but don't currently overlap on shipped themes. inlabru is currently shipping more aggressively (velocity 2.5 vs 0.0), with 0 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. inlabru is currently shipping more aggressively (velocity 2.5 vs 0.0), with 0 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Infra & APIs products to evaluate alongside.
Top inlabru alternatives in Infra & APIs are ranked by recent ship velocity. Browse the "inlabru alternatives" section above for the current picks, or visit /alternatives/inlabru for the full list with editorial commentary on each.
Top PowerTOST alternatives in Infra & APIs are ranked by recent ship velocity. Browse the "PowerTOST alternatives" section above for the current picks, or visit /alternatives/powertost for the full list with editorial commentary on each.